Market Cap 138.10M
Revenue (ttm) 138.90M
Net Income (ttm) -107.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -77.14%
Debt to Equity Ratio 0.00
Volume 795,800
Avg Vol 910,668
Day's Range N/A - N/A
Shares Out 47.29M
Stochastic %K 28%
Beta 1.07
Analysts Hold
Price Target $3.33

Company Profile

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all comp...

Industry: Medical Devices
Sector: Healthcare
Phone: 617 301 9400
Address:
Building 1, 900 Middlesex Turnpike, Billerica, United States
stkmkt
stkmkt Aug. 18 at 7:19 PM
$QTRX Did some research on this stock... Here are my pros and cons for $QTRX. Pros: • New commercial leadership • Cash in Hand: $96.9 million cash. • Cash burn: $4-$5.7 million/quarter (~20 mil per year) • Total Debt: $0 • No immediate risk of equity dilution or bankruptcy • Possible additional revenue from Akoya acquisition. Cons: • Softer market spending from academic, pharmaceutical clients and Government Funding • Cash-flow breakeven target out to 2027. Overall company is trading near its historical lows and IMHO, it is a buy at this level. Feel free to add/correct any points.
0 · Reply
anachartanalyst
anachartanalyst Aug. 17 at 8:02 PM
$QTRX https://anachart.com/wp-content/uploads/2026/08/1786996911_soc-img.jpg
0 · Reply
Valueforall
Valueforall Aug. 14 at 4:50 PM
$QTRX trading at levels near cash and kitchen sinking ‘26 has me bottom dwelling this one. Only watching for now
0 · Reply
bosha
bosha Aug. 13 at 1:32 PM
$QTRX Too many talk but no walk, give me a break.
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 12 at 4:08 PM
$QTRX so much for $2 near term i'd like to see a pullback, won't add now more power to those holding may you breakeven and then some
0 · Reply
Pika_Capital
Pika_Capital Aug. 11 at 8:21 PM
$SEER $CDXS $QTRX $TXG Lmao entire life sciences landscape is a total joke. Tons of garbage is trading at 90% discount. Some of these down the road will recover but most of them will disappear
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 11 at 4:03 PM
$QTRX took a few this am
0 · Reply
Biorocksme
Biorocksme Aug. 11 at 7:43 AM
$QTRX $TENX Whacked you bio trash. Damn. Choose carefully. Or die
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 11 at 4:04 AM
$QTRX took a starter near the close anyone think we see some form 4s for insuder buys before the week is out
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Aug. 10 at 8:18 PM
$QTRX Hello again! Now down 39% in 5 months since post. Are we there yet (half of cash) ???
1 · Reply
Latest News on QTRX
Quanterix price target lowered to $3 from $4 at Canaccord

2026-08-17T11:05:48.000Z - 1 day ago

Quanterix price target lowered to $3 from $4 at Canaccord


Quanterix price target lowered to $3 from $4 at TD Cowen

2026-08-11T11:45:11.000Z - 7 days ago

Quanterix price target lowered to $3 from $4 at TD Cowen


Quanterix Earnings Call Transcript: Q2 2026

Aug 10, 2026, 8:30 AM EDT - 8 days ago

Quanterix Earnings Call Transcript: Q2 2026


Quanterix Earnings release: Q2 2026

Aug 10, 2026, 8:30 AM EDT - 8 days ago

Quanterix Earnings release: Q2 2026


Quanterix Slides: Q2 2026

Aug 10, 2026, 8:30 AM EDT - 8 days ago

Quanterix Slides: Q2 2026


Quanterix Quarterly report: Q2 2026

Aug 10, 2026, 8:30 AM EDT - 8 days ago

Quanterix Quarterly report: Q2 2026


Quanterix appoints Gute as Chief Commercial Officer

2026-08-10T12:06:04.000Z - 8 days ago

Quanterix appoints Gute as Chief Commercial Officer


Quanterix reports Q2 EPS ($1.04), consensus (41c)

2026-08-10T12:05:32.000Z - 8 days ago

Quanterix reports Q2 EPS ($1.04), consensus (41c)


Quanterix sees FY26 revenue $142M-$148M, consensus $169.86M

2026-08-10T12:05:16.000Z - 8 days ago

Quanterix sees FY26 revenue $142M-$148M, consensus $169.86M


Quanterix Names Jim Gute Chief Commercial Officer

Aug 10, 2026, 8:01 AM EDT - 8 days ago

Quanterix Names Jim Gute Chief Commercial Officer


Quanterix appoints Faessler as Chief Financial Officer

2026-06-09T12:11:58.000Z - 2 months ago

Quanterix appoints Faessler as Chief Financial Officer

BRKR


Quanterix announces CFO transition

2026-05-12T22:15:56.000Z - 3 months ago

Quanterix announces CFO transition


Quanterix Proxy statement: Proxy filing

May 8, 2026, 8:00 AM EDT - 3 months ago

Quanterix Proxy statement: Proxy filing


Quanterix price target lowered to $4 from $7 at TD Cowen

2026-05-07T20:14:51.000Z - 3 months ago

Quanterix price target lowered to $4 from $7 at TD Cowen


Lucent Diagnostics announces collaboration with Tempus AI

2026-05-07T06:21:33.000Z - 3 months ago

Lucent Diagnostics announces collaboration with Tempus AI

TEM


Quanterix reports Q1 EPS (37c), consensus (62c)

2026-05-07T01:49:19.000Z - 3 months ago

Quanterix reports Q1 EPS (37c), consensus (62c)


Quanterix affirms 2026 revenue outlook $169M-$174M

2026-05-07T01:48:11.000Z - 3 months ago

Quanterix affirms 2026 revenue outlook $169M-$174M


Quanterix Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

Quanterix Earnings Call Transcript: Q1 2026


Quanterix Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

Quanterix Slides: Q1 2026


Quanterix Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

Quanterix Earnings release: Q1 2026


Quanterix Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

Quanterix Quarterly report: Q1 2026


Quanterix Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Quanterix Proxy statement: Proxy filing


Quanterix price target lowered to $4 from $8 at Canaccord

2026-04-20T14:08:55.000Z - 4 months ago

Quanterix price target lowered to $4 from $8 at Canaccord


Quanterix, PreludeDX highlights AidaBREAST multi-omic assay

2026-04-17T12:56:49.000Z - 4 months ago

Quanterix, PreludeDX highlights AidaBREAST multi-omic assay


Quanterix debuts Content Innovation Engine at AACR 2026

2026-04-15T12:40:49.000Z - 4 months ago

Quanterix debuts Content Innovation Engine at AACR 2026


Quanterix Debuts Content Innovation Engine at AACR 2026

Apr 15, 2026, 8:33 AM EDT - 4 months ago

Quanterix Debuts Content Innovation Engine at AACR 2026


Quanterix Corporation Announces Date of 2026 Annual Meeting

Mar 27, 2026, 4:00 PM EDT - 5 months ago

Quanterix Corporation Announces Date of 2026 Annual Meeting


Quanterix Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 1:00 PM EDT - 5 months ago

Quanterix Transcript: Leerink Global Healthcare Conference 2026


Quanterix Earnings Call Transcript: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Quanterix Earnings Call Transcript: Q4 2025


Quanterix Annual report: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Quanterix Annual report: Q4 2025


Quanterix Earnings release: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Quanterix Earnings release: Q4 2025


Quanterix Slides: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Quanterix Slides: Q4 2025


Quanterix reports Q4 EPS (49c) vs. (30c) last year

2026-03-02T21:06:31.000Z - 6 months ago

Quanterix reports Q4 EPS (49c) vs. (30c) last year


Quanterix sees FY26 revenue $169M-$174M, consensus $168.8M

2026-03-02T21:05:34.000Z - 6 months ago

Quanterix sees FY26 revenue $169M-$174M, consensus $168.8M


Quanterix to Participate in Upcoming Investor Conferences

Feb 26, 2026, 8:33 AM EST - 6 months ago

Quanterix to Participate in Upcoming Investor Conferences


Quanterix names Everett Cunningham president, CEO

2026-01-08T21:36:14.000Z - 7 months ago

Quanterix names Everett Cunningham president, CEO


Quanterix Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:30 PM EST - 10 months ago

Quanterix Earnings Call Transcript: Q3 2025


Quanterix Quarterly report: Q3 2025

Nov 10, 2025, 4:30 PM EST - 10 months ago

Quanterix Quarterly report: Q3 2025


Quanterix Earnings release: Q3 2025

Nov 10, 2025, 4:30 PM EST - 10 months ago

Quanterix Earnings release: Q3 2025


Quanterix Slides: Q3 2025

Nov 10, 2025, 4:30 PM EST - 10 months ago

Quanterix Slides: Q3 2025


Quanterix Releases Financial Results for the Third Quarter of 2025

Nov 10, 2025, 4:01 PM EST - 10 months ago

Quanterix Releases Financial Results for the Third Quarter of 2025


Quanterix Proxy statement: Proxy Filing

Sep 24, 2025, 8:00 AM EDT - 11 months ago

Quanterix Proxy statement: Proxy Filing


Quanterix Proxy statement: Proxy Filing

Aug 25, 2025, 8:00 AM EDT - 1 year ago

Quanterix Proxy statement: Proxy Filing


Quanterix Proxy statement: Proxy Filing

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Quanterix Proxy statement: Proxy Filing


Quanterix Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Quanterix Earnings Call Transcript: Q2 2025


Quanterix Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Quanterix Quarterly report: Q2 2025


Quanterix Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Quanterix Earnings release: Q2 2025


Quanterix Slides: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Quanterix Slides: Q2 2025


Quanterix Expands Reach with IVD and Large Reference Labs

Jun 23, 2025, 7:30 AM EDT - 1 year ago

Quanterix Expands Reach with IVD and Large Reference Labs


Quanterix Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Quanterix Earnings Call Transcript: Q1 2025


Quanterix Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Quanterix Quarterly report: Q1 2025


Quanterix Earnings release: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Quanterix Earnings release: Q1 2025


Quanterix Slides: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Quanterix Slides: Q1 2025


Quanterix Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Quanterix Proxy statement: Proxy Filing


Quanterix Proxy statement: Proxy Filing

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Quanterix Proxy statement: Proxy Filing


stkmkt
stkmkt Aug. 18 at 7:19 PM
$QTRX Did some research on this stock... Here are my pros and cons for $QTRX. Pros: • New commercial leadership • Cash in Hand: $96.9 million cash. • Cash burn: $4-$5.7 million/quarter (~20 mil per year) • Total Debt: $0 • No immediate risk of equity dilution or bankruptcy • Possible additional revenue from Akoya acquisition. Cons: • Softer market spending from academic, pharmaceutical clients and Government Funding • Cash-flow breakeven target out to 2027. Overall company is trading near its historical lows and IMHO, it is a buy at this level. Feel free to add/correct any points.
0 · Reply
anachartanalyst
anachartanalyst Aug. 17 at 8:02 PM
$QTRX https://anachart.com/wp-content/uploads/2026/08/1786996911_soc-img.jpg
0 · Reply
Valueforall
Valueforall Aug. 14 at 4:50 PM
$QTRX trading at levels near cash and kitchen sinking ‘26 has me bottom dwelling this one. Only watching for now
0 · Reply
bosha
bosha Aug. 13 at 1:32 PM
$QTRX Too many talk but no walk, give me a break.
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 12 at 4:08 PM
$QTRX so much for $2 near term i'd like to see a pullback, won't add now more power to those holding may you breakeven and then some
0 · Reply
Pika_Capital
Pika_Capital Aug. 11 at 8:21 PM
$SEER $CDXS $QTRX $TXG Lmao entire life sciences landscape is a total joke. Tons of garbage is trading at 90% discount. Some of these down the road will recover but most of them will disappear
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 11 at 4:03 PM
$QTRX took a few this am
0 · Reply
Biorocksme
Biorocksme Aug. 11 at 7:43 AM
$QTRX $TENX Whacked you bio trash. Damn. Choose carefully. Or die
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 11 at 4:04 AM
$QTRX took a starter near the close anyone think we see some form 4s for insuder buys before the week is out
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Aug. 10 at 8:18 PM
$QTRX Hello again! Now down 39% in 5 months since post. Are we there yet (half of cash) ???
1 · Reply
HK_Zhou
HK_Zhou Aug. 10 at 4:18 PM
$QTRX Breakeven in 2027!!
0 · Reply
HK_Zhou
HK_Zhou Aug. 10 at 4:17 PM
$QTRX Bought some , 3 dollars target.. They have 80 million cash... They can survive. Current price is bankrupcy price.
0 · Reply
pilobious
pilobious Aug. 10 at 4:14 PM
$QTRX from today’s report “Quanterix now anticipates achieving cash flow breakeven in 2027 but is currently forecasting approximately $80 million for the 2026 year-end cash balance, compared to $100 million previously. The company expects to end the year with no debt” So the enterprise value will be only $40 million at year end based on a $2.50 stock price. Market cap is $120 million as of today unless I’m missing some preferred. Unreal cheap. If you believe management that is.
0 · Reply
EarningsInsider
EarningsInsider Aug. 10 at 1:47 PM
https://www.marketbeat.com/earnings/reports/2026-8-10-quanterix-co-stock/ $QTRX Quanterix Earnings Transcript
0 · Reply
Pika_Capital
Pika_Capital Aug. 10 at 1:39 PM
$QTRX they are done. Huge miss. Stay away for now.
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 10 at 1:26 PM
$QTRX are they at the point where they must entertain offers for the company?
2 · Reply
thedavidsonny
thedavidsonny Aug. 10 at 1:16 PM
$QTRX 💎 💎 💎 💎 💎 💎 Coming soon 💰 🤑 💸 💲 🪙 💶 💰
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Aug. 10 at 1:14 PM
$QTRX anybody cash out on the run up ? these are some putrid looking numbers new lows for sure....
1 · Reply
Zaksab
Zaksab Aug. 10 at 12:49 PM
$QTRX CEO will have to scale Mount Everett from here…
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 10 at 12:48 PM
QTRX Q2 2026 Earnings Summary $QTRX https://stocktwits.com/news/earnings/earnings/qtrx-q2-2026-earnings-summary/cZojYo3RJOX
0 · Reply
focafoca99
focafoca99 Aug. 10 at 12:24 PM
$QTRX captured its Q2 2026 earnings, issuing a press release with results for the quarter ended June 30, 2026.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 10 at 12:22 PM
$QTRX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.04 down -35.06% YoY • Reported revenue of $32.91M up 34.44% YoY • Quanterix expects full-year 2026 revenues of $142-148 million, non-GAAP gross margins of 48-50%, and anticipates achieving cash flow breakeven in 2027 while forecasting an $80 million year-end cash balance.
0 · Reply